alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 1026 Introduced in Senate (IS)]

<DOC>

118th CONGRESS
  1st Session
                                S. 1026

  To authorize the appropriation of funds to the Centers for Disease 
    Control and Prevention for conducting or supporting research on 
              firearms safety or gun violence prevention.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 29, 2023

 Mr. Markey (for himself, Ms. Duckworth, Ms. Cortez Masto, Mr. Kaine, 
 Ms. Smith, Mr. Casey, Mr. Murphy, Mr. Booker, Mr. Welch, Mr. Carper, 
 Mr. Merkley, Mrs. Feinstein, Mr. Reed, Ms. Warren, Ms. Cantwell, Mr. 
  Whitehouse, Mr. Wyden, Mr. Menendez, Ms. Klobuchar, Ms. Hirono, Mr. 
  Durbin, Mr. Sanders, Mr. Schatz, Mr. Blumenthal, Mr. Heinrich, Mrs. 
Gillibrand, Ms. Baldwin, and Mr. Coons) introduced the following bill; 
     which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
  To authorize the appropriation of funds to the Centers for Disease 
    Control and Prevention for conducting or supporting research on 
              firearms safety or gun violence prevention.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Gun Violence Prevention Research Act 
of 2023''.

SEC. 2. FUNDING FOR RESEARCH BY CDC ON FIREARMS SAFETY OR GUN VIOLENCE 
              PREVENTION.

    There is authorized to be appropriated to the Centers for Disease 
Control and Prevention $50,000,000 for each of fiscal years 2024 
through 2029 for the purpose of conducting or supporting research on 
firearms safety or gun violence prevention under the Public Health 
Service Act (42 U.S.C. 201 et seq.). The amount authorized to be 
appropriated by the preceding sentence is in addition to any other 
amounts authorized to be appropriated for such purpose.
                                 <all>
```
Bernard JOHNSON, Appellant, v. STATE of Florida, Appellee.

No. 1D17-3510

District Court of Appeal of Florida, First District.

January 26, 2018 Rehearing Denied March 23, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
T.G.A., JR., Appellant/Petitioner(s), v. DEPT. OF CHILDREN & FAMILIES, Appellee/Respondent(s).

CASE NO.: 2D17-0641

District Court of Appeal of Florida, Second District.

March 02, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
**Exhibit 32.1**

**Certification ofChief Executive Officer ofAdvance America, Cash Advance Centers, Inc.Pursuant to 18 U.S.C. Section 1350(Adopted by Section 906 of the Sarbanes-Oxley Act of 2002)**

**Inconnection with the Annual Report on Form 10-K of Advance America,Cash Advance Centers, Inc. (the “Company”) for the year ended December 31,2006, as filed with the Securities and Exchange Commission (the “Report”), I, KennethE. Compton, President and Chief Executive Officer, certify, pursuant to 18U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that:**

1.                The Report fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934, and

2.                The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

|                    | /s/ Kenneth E. Compton                  |   |
|--------------------|-----------------------------------------|--------|
|                    | Kenneth E. Compton                      |
| * *           | *President and Chief Executive Officer* |
| March 1, 2007 |                                    |

 

----
**Exhibit 31.2**

 

**CERTIFICATION**

 

I, David C. Bushnell, certify that:

 

1.          Ihave reviewed this Annual Report on Form 10-K of Cordia Bancorp Inc.;

 

2.          Basedon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under which such statements were made, not misleading with respect tothe period covered by this report;

 

3.          Basedon my knowledge, the financial statements, and other financial information included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presentedin this report;

 

4.          Theregistrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures(as defined in Exchange Act Rules 13a-15(e) for the registrant and have:

 

(a)          Designedsuch disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is being prepared;

 

(b)          N/A;

 

(c)          Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions aboutthe effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;and

 

(d)          Disclosedin this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’smost recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected,or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.          Theregistrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control overfinancial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (orpersons performing the equivalent functions):

 

(a)          Allsignificant deficiencies and material weaknesses in the design or operation of internal control over financial reporting whichare reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information;and

 

(b)          Anyfraud, whether or not material, that involves management or other employees who have a significant role in the registrant’sinternal control over financial reporting.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-28-1997
<PERIOD-END>                               JUN-29-1997
<CASH>                                          98,027
<SECURITIES>                                         0
<RECEIVABLES>                                   47,658
<ALLOWANCES>                                         0
<INVENTORY>                                     55,098
<CURRENT-ASSETS>                               209,972
<PP&E>                                         291,730
<DEPRECIATION>                                 151,705
<TOTAL-ASSETS>                                 355,435
<CURRENT-LIABILITIES>                           42,511
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           548
<OTHER-SE>                                     312,924
<TOTAL-LIABILITY-AND-EQUITY>                   355,435
<SALES>                                         91,040
<TOTAL-REVENUES>                                91,040
<CGS>                                           44,627
<TOTAL-COSTS>                                   69,549
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 22,616
<INCOME-TAX>                                     7,294
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    15,322
<EPS-PRIMARY>                                      .52
<EPS-DILUTED>                                        0
        

</TABLE>
99.1

Annual Certification

Re:  Finance America Home Loan Trust (the "Trust"), Asset Backed
Certificates, Series 2004-2, issued pursuant to the Pooling and
Servicing Agreement, dated as August 1, 2004 (the "Pooling and
Servicing Agreement"), by and among Financial Asset Securities
Corp., as depositor (the "Depositor"), Deutsche Bank National
Trust Company, as trustee (the "Trustee"), and HomEq
Servicing Corporation, as servicer (the "Servicer")

I, Arthur Q. Lyon, certify to the Depositor and the Trustee, and their
officers, directors and affiliates, and with the knowledge and intent
that they will rely upon this certification, that:

A review of the activities of the Servicer during the 2004 calendar year
and the Servicer's performance under the Pooling and Servicing Agreement
has been made under my supervision, the Servicer has complied with the
Pooling and Servicing Agreement in all material respects and, to the best
of my knowledge, based on such review, the Servicer has materially fulfilled
all of its obligations under the Pooling and Servicing Agreement throughout
such calendar year.

Date:  March 14, 2005

HomEq Servicing Corporation

By:  /s/:  Arthur Q. Lyon
           Arthur Q. Lyon
           President
|                        | Winland Electronics, Inc. |                                  |
|-----------------------------|---------------------------|---------------------------------------|
|                        |                      |                                  |   |
| Date:  August 13, 2009 | By:                       | /s/ Thomas J. de Petra           |   |
|                        |                      | Thomas J. de Petra                    |   |
|                        |                      | President and Chief Executive Officer |   |
|                        |                      |                                  |   |
### Regul a tory Evaluation
Docket No. 

### FAA -1d 

## iS'- i 

## t3 Q Direct o r ate Identifier: 2015

- CE-008-AD



## If

you make changes to the values in the table below
. you must ensure the totals update accordingly. 

## If they do not , click (or Tab) into and then out of the changed cell
. Estimated Costs: Action Costs per Product (e.g., aircraft, en g ine, (e.g . , Inspect i on, propeller, applian ce) Work

-hours Labor Parts Cost Total C o s ts Number of Total Cost replacement) (include cost (labor + 

## u.s. for U.S
. Fleet Do not includ e on condition costs h er e access, testing , (@$85/h parts ) Registered and close-up) our) Products 

### Add Limitation 0.5 $0 2 Axle Removal , Inspection, 

### & 1.5 

### 2 Reinstallation

t

The know n number of products in compliance: 0 Total Costs of compliance for U.S. fleet: $340 Costs covered under warranty 

### (if known) $0 On-Condition Costs: Action Work-hours Labor co st Parts Co st Cos t per Produc t (e.g. , Inspection , ( include ac cess, (@$ 85/ho ur ) replacement) testing , and closeup)



### Special considerations for Economic Analysis (Use this field to explain anyth ing in th e Estim a t e d Costs tabl e that was assum ed or might not b e o b vious. Thisfield can also be used to explain warranty costs): The engine

### supplier Solo Kleinmotoren currently has no certified replacement axle to offer if cracks are found during the inspection. Once a replacement axle is certified , Solo will issue a new Service Bulletin. Executive Order 12866: Could the AD be considered a "significant regulatory action"? 

# 8 YE S* 

# D N0[8] *Explanation: 

### DOT Regulatory Policies and Procedures: Is the AD significant? 

# G YES* 

## D N0[8] *Ex planation : 

### Regulatory Flexibility Act: Will the AD have a significant economic impact on a substantial number of

**sm~ll** entities? Explain for either a Yes or No answer. 

# G YESD N0[8] Exp lanation: 

### The AD only affects 2 US registered aircraft. Intrastate Aviation in Alaska: This AD could affect intrastate aviation in Alaska. Is it appropriate to include specific requirements for aircraft operated in Alaska where aviation might be the only mode of transportation? 

# G YES* 

# D N0[8] *Expla nation:
Alfred MCDONALD, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-5667

District Court of Appeal of Florida, Second District.

Opinion filed October 4, 2017.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
A.S., a Juvenile, Appellant, v. The STATE of Florida, Appellee.

No. 3D17-1696

District Court of Appeal of Florida, Third District.

Opinion filed January 17, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Document

Exhibit 10.43 H


SEVENTH AMENDMENT TO THE PIONEER NATURAL RESOURCES USA, INC. 
401(k) AND MATCHING PLAN 
(Amended and Restated Effective as of January 1, 2020)


THIS SEVENTH AMENDMENT is made and entered into by Pioneer Natural Resources USA, Inc. (the “Company”):
WITNESSETH:


WHEREAS, the Company maintains the Pioneer Natural Resources USA, Inc. 401(k) and Matching Plan (the “Plan”);


WHEREAS, pursuant to Section 8.3 of the Plan, the Benefit Plan Design Committee (the “Committee”) of the Company maintains the authority to amend the Plan at any time; and


WHEREAS, effective November 3, 2021 (the “Effective Date”), the Committee desires to amend the Plan to provide for full and immediate vesting in any employer-derived benefits accrued under the Plan for certain employees who are involuntarily terminated in connection with the sale of the assets in the Delaware Basin. 


NOW THEREFORE, the Plan is hereby amended as of the Effective Date as follows:
1.         Section 5.3(z) is hereby added to the Plan as follows:


(z)        Any provision of this Plan to the contrary notwithstanding, the amounts credited to the Employer Account of a Participant who is specifically designated by the Vice President, Human Resources of the Company as being involuntarily terminated in connection with the sale of the assets in the Delaware Basin announced by the Company on November 3, 2021 shall become fully vested and nonforfeitable on the date of such involuntary termination. 


NOW, THEREFORE, be it further provided that except as provided above, the Plan shall continue to read in its current state.


IN WITNESS WHEREOF, the Company has executed this Seventh Amendment this 2nd day of December 2021 to be effective as specified above.


                                                                        PIONEER NATURAL RESOURCES USA, INC.




                                                                                    By: /s/ Tyson L. Taylor
                                                                                    Name: Tyson Taylor
            Title: Vice President, Human Resources
IN THE

TENTH COURT OF APPEALS

No. 10-10-00308-CV

RYAN HANSON,

Appellant

v.

ERVING JENSEN, KENNETH DEAN AND

CHERYL LAWSON,

Appellees

From the 52nd District Court

Coryell County, Texas

Trial Court No. COT-10-39673

MEMORANDUM OPINION

Appellant has filed a motion to dismiss this appeal. Appellees have not filed a 

response. Accordingly, the appeal is dismissed. See TEX. R. APP. P. 42.1(a)(1).

FELIPE REYNA

Justice 

Before Chief Justice Gray,

Justice Reyna, and

Justice Davis

Appeal dismissed

Opinion delivered and filed October 27, 2010

[CV06]
James T. LOVERN, Appellant/Petitioner(s), v. U.S. BANK NATIONAL ASSOCIATION, et al., Appellee/Respondent(s).

CASE NO.: 2D16-4651

District Court of Appeal of Florida, Second District.

October 27, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
Todrick ROBERTS a/k/a Natan Torres, Appellant, v. The STATE of Florida, Appellee.

No. 3D17-2322

District Court of Appeal of Florida, Third District.

Opinion filed December 27, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
# Europos Sąjungos C 447I/2020

| | ISSN 1977-0960 |
| --- | --- |
| Europos Sąjungos
  oficialusis leidinys | C 447I |
| | |
| Leidimas lietuvių kalba | Informacija ir pranešimai | 63 metai2020m. gruodžio 24d. |

ISSN 1977-0960

Europos Sąjungos

oficialusis leidinys

C 447I

Leidimas lietuvių kalba

Informacija ir pranešimai

63 metai2020m. gruodžio 24d.

---

| Turinys | Puslapis |
| --- | --- |
| | IV   Pranešimai |
| | EUROPOS SĄJUNGOS INSTITUCIJŲ, ĮSTAIGŲ IR ORGANŲ PRANEŠIMAI |
| | Europos Komisija |
| 2020/C 447 I/01 | Europos Sąjungos sprendimų dėl vaistų rinkodaros leidimų santrauka nuo 21 December 2020 iki 21 December 2020( OL C 136, 2004 4 30 ) | 1 |

Turinys

Puslapis

IV   Pranešimai

EUROPOS SĄJUNGOS INSTITUCIJŲ, ĮSTAIGŲ IR ORGANŲ PRANEŠIMAI

Europos Komisija

2020/C 447 I/01

Europos Sąjungos sprendimų dėl vaistų rinkodaros leidimų santrauka nuo 21 December 2020 iki 21 December 2020( OL C 136, 2004 4 30 )

( OL C 136, 2004 4 30 )

1

---

| LT | |
| --- | --- |

LT

---

IV Pranešimai

EUROPOS SĄJUNGOS INSTITUCIJŲ, ĮSTAIGŲ IR ORGANŲ PRANEŠIMAI

Europos Komisija

| 2020 12 24 | LT | Europos Sąjungos oficialusis leidinys | CI 447/1 |
| --- | --- | --- | --- |

2020 12 24

LT

Europos Sąjungos oficialusis leidinys

CI 447/1

---

Europos Sąjungos sprendimų dėl vaistų rinkodaros leidimų santrauka nuo 21 December 2020 iki 21 December 2020

(Paskelbta pagal Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 (1)
  13 straipsnį arba 38 straipsnį)

(2020/C 447 I/01)

| — | Rinkodaros leidimo suteikimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 13 straipsnis): Priimta |
| --- | --- |

—

Rinkodaros leidimo suteikimas (Europos Parlamento ir Tarybos reglamento (EB) Nr. 726/2004 13 straipsnis): Priimta

| Sprendimo data | Vaisto pavadinimas | INN (Tarptautinis nepatentuotas pavadinimas) | Rinkodaros leidimo turėtojas | Įrašo numeris Bendrijos vaistų registre | Farmacinė forma | ATC kodas (Anatominis terapinis cheminis kodas) | Pranešimo data |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 21.12.2020 | Comirnaty | COVID-19 mRNR vakcina (modifikuotais nukleozidais) | BioNTech Manufacturing GmbH An der Goldgrube 12, 55131 Mainz, Deutschland | EU/1/20/1528 | Koncentratas injekcinei dispersijai | J07BX | 21.12.2020 |

Sprendimo data

Vaisto pavadinimas

INN (Tarptautinis nepatentuotas pavadinimas)

Rinkodaros leidimo turėtojas

Įrašo numeris Bendrijos vaistų registre

Farmacinė forma

ATC kodas (Anatominis terapinis cheminis kodas)

Pranešimo data

21.12.2020

Comirnaty

COVID-19 mRNR vakcina (modifikuotais nukleozidais)

BioNTech Manufacturing GmbH An der Goldgrube 12, 55131 Mainz, Deutschland

EU/1/20/1528

Koncentratas injekcinei dispersijai

J07BX

21.12.2020

Norintieji susipažinti su nagrinėjamųjų vaistų vieša vertinimo ataskaita ir su ja susijusiais sprendimais, gali kreiptis į:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NETHERLANDS |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

---

(1)  OL L 136, 2004 4 30, p. 1.

---
Ryan Bradley SMITH, Appellant, v. Melanie Lyne SMITH, Appellee.

Case No. 2D16-4944

District Court of Appeal of Florida, Second District.

Opinion filed December 6, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
M.N.M., the Mother, Appellant(s)/Petitioner(s), v. The DEPARTMENT OF CHILDREN, etc., et al., Appellee(s)/Respondent(s),

CASE NO.: 3D16-2555

District Court of Appeal of Florida, Third District.

JANUARY 23, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
----

----

I Informace

Komise

----

SPOLEČNÝ KATALOG ODRŮD DRUHŮ ZEMĚDĚLSKÝCH ROSTLIN

Pátý dodatek k 23. úplnému vydání

(2005/C 196 A/01)

OBSAH

Legenda

Seznam druhů zemědělských rostlin

----

LEGENDA

----

(1)Úř. věst. C 46 A, 22.2.2005, s. 1. Katalog naposledy pozměněný čtvrtým. dodatkem (Úř. věst. C 145 A, 15.6.2005, s. 1).

(2)Úř. věst. L 193, 20.7.2002, s. 1. Směrnice naposledy pozměněná nařízením Evropského parlamentu a Rady (ES) č. 1829/2003 (Úř. věst. L 268, 18.10.2003, s. 1).

----

I

1.BETA VULGARIS L.

2.BETA VULGARIS L.

II

3.AGROSTIS CANINA L.

5.AGROSTIS STOLONIFERA L.

6.AGROSTIS CAPILLARIS L.

7.ALOPECURUS PRATENSIS L.

9.BROMUS CATHARTICUS VAHL

10.BROMUS SITCHENSIS TRIN.

12.DACTYLIS GLOMERATA L.

13.FESTUCA ARUNDINACEA SCHREBER

14.FESTUCA OVINA L.

15.FESTUCA PRATENSIS HUDSON

16.FESTUCA RUBRA L.

16A.× FESTULOLIUM

17.LOLIUM MULTIFLORUM LAM.

18.LOLIUM PERENNE L.

19.LOLIUM × BOUCHEANUM KUNTH

21.PHLEUM BERTOLONII DC.

22.PHLEUM PRATENSE L.

26.POA PRATENSIS L.

31.LUPINUS ALBUS L.

35.MEDICAGO SATIVA L.

38.PISUM SATIVUM L. (PARTIM)

39.TRIFOLIUM ALEXANDRINUM L.

41.TRIFOLIUM INCARNATUM L.

42.TRIFOLIUM PRATENSE L.

43.TRIFOLIUM REPENS L.

46.VICIA FABA L. (PARTIM)

47.VICIA PANNONICA CRANTZ

48.VICIA SATIVA L.

50.BRASSICA NAPUS L. VAR. NAPOBRASSICA (L.) RCHB.

51.BRASSICA OLERACEA L. CONVAR. ACEPHALA (DC.) ALEF. VAR. MEDULLOSA THELL. + VAR. VIRIDIS L.

52.PHACELIA TANACETIFOLIA BENTH.

53.RAPHANUS SATIVUS L. VAR. OLEIFORMIS PERS.

III

55.BRASSICA RAPA L. VAR. SILVESTRIS (LAM.) BRIGGS

56.BRASSICA JUNCEA (L.) CZERNJ ET COSSON

57.BRASSICA NAPUS L. (PARTIM)

60.CARTHAMUS TINCTORIUS L.

61.CARUM CARVI L.

62.GOSSYPIUM SPP.

63.HELIANTHUS ANNUUS L.

64.LINUM USITATISSIMUM L.

65.PAPAVER SOMNIFERUM L.

66.SINAPIS ALBA L.

67.GLYCINE MAX (L.) MERRILL

IV

68.AVENA SATIVA L.

69.HORDEUM VULGARE L.

70.ORYZA SATIVA L.

72.SECALE CEREALE L.

73.SORGHUM BICOLOR (L.) MOENCH

75.SORGHUM BICOLOR (L.) MOENCH × SORGHUM SUDANENSE (PIPER) STAPF.

76.× TRITICOSECALE WITTM.

77.TRITICUM AESTIVUM L. EMEND. FIORI ET PAOL.

78.TRITICUM DURUM DESF.

79.TRITICUM SPELTA L.

80.ZEA MAYS L.

V

81.SOLANUM TUBEROSUM L.

----
21ST CENTURY NORTH AMERICA INS. CO., Appellant/Petitioner(s), v. Lori KALNASKY, as Personal Representative, et al., Appellee/Respondent(s).

CASE NO.: 2D17-3690

District Court of Appeal of Florida, Second District.

October 10, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.